Parkinson's disease (idiopathic parkinsonism or paralysis agitans) is characterized clinically
by progressive tremor, bradykinesia, and rigidity and pathologically by degeneration of the …

… Parkinson's disease (PD) affects one in every 100 persons above the age of 65 years, …
most common neurodegenerative disease after Alzheimer's disease. PD is a disease of the …

… advances in the treatment of PD, it is important to note that new treatments are not necessarily
better than the established conventional therapy and that the treatment options must be …

… therapies for the treatment of Parkinson's disease. In this … , and thalamus for the treatment
of Parkinson's disease. Recent … for the treatment of Parkinson's disease are moving forward …

… disease-modifying treatments. However, the requirement for relevant pre-clinical disease …
the identification of prodromal disease, which would allow for treatment before significant …

… less improvement on the Unified Parkinson Disease Rating Scale (UPDRS) than those
started on levodopa, even though patients in either treatment group could receive supplemental …

Objectives: Parkinson's Disease (PD) is estimated to affect over 1 percent of the population
over age 65. The objective of this systematic review is to assess the quantity and quality of …

Deep brain stimulation (DBS) is a neurosurgical treatment of Parkinson's disease that is
applied to three targets: the ventral intermediate nucleus of the thalamus (Vim), the globus …

… Parkinson's disease (PD) is the second most common neurodegenerative disorder after
Alzheimer's disease and … of this disease, and these have underpinned advances in symptomatic …

… that were relevant to Parkinson disease diagnosis and treatment. The second … treatment
or diagnosis of Parkinson disease (rather than diagnosis of components of Parkinson disease […